A multicenter seroepidemiological study of SARS-CoV-2 antibody prevalence in oral surgery medical staff.

A multicenter seroepidemiological study of SARS-CoV-2 antibody prevalence in oral surgery medical staff. - A multicenter seroepidemiological study of SARS-CoV-2 antibody prevalence in oral surgery medical staff.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043788

Enrollment

300

Registered

2021-03-30

Start date

2021-02-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Blood sampling (5 ml) will be performed once during the study period.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Persons who are employees in the field of oral surgery (dentists, dental hygienists, nurses, dental technicians) and who have obtained the consent of the document by their own free will after fully understanding when participating in this study.

Exclusion criteria

Exclusion criteria: Persons who are judged to be ineligible for this study by the principal investigator.

Design outcomes

Primary

Measure	Time frame
the SARS-CoV-2 antibody prevalence in oral surgery medical staff	—

Countries

Japan

Contacts

Public ContactYoko Koga

Tokyo Women's Medical University, School of Medicine Department of Oral and Maxillofacial Surgery

koga.yoko@twmu.ac.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026